Ryman Healthcare (NZSE:RYM) Valuation Check As Earnings Outlook And Profitability Plans Come Into Focus

Simply Wall St.08:52

Ryman Healthcare (NZSE:RYM) has moved into focus after its stock declined ahead of the upcoming 26 May earnings report, with investors watching closely for commentary on profitability pressures and ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2637369792?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6033000-choice2-main-header/1585186569462","is_english":true,"pubTime":"2026-05-22 08:52","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2637369792","market":"hk","top_or_hot":-1,"title":"Ryman Healthcare (NZSE:RYM) Valuation Check As Earnings Outlook And Profitability Plans Come Into Focus","media":"Simply Wall St.","content":"<div>\n<p>Ryman Healthcare (NZSE:RYM) has moved into focus after its stock declined ahead of the upcoming 26 May earnings report, with investors watching closely for commentary on profitability pressures and ...</p>\n\n<a href=\"https://simplywall.st/stocks/nz/healthcare/nzx-rym/ryman-healthcare-shares/news/ryman-healthcare-nzserym-valuation-check-as-earnings-outlook\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ryman Healthcare (NZSE:RYM) Valuation Check As Earnings Outlook And Profitability Plans Come Into Focus</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRyman Healthcare (NZSE:RYM) Valuation Check As Earnings Outlook And Profitability Plans Come Into Focus\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-05-22 08:52 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/nz/healthcare/nzx-rym/ryman-healthcare-shares/news/ryman-healthcare-nzserym-valuation-check-as-earnings-outlook><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Ryman Healthcare (NZSE:RYM) has moved into focus after its stock declined ahead of the upcoming 26 May earnings report, with investors watching closely for commentary on profitability pressures and ...</p>\n\n<a href=\"https://simplywall.st/stocks/nz/healthcare/nzx-rym/ryman-healthcare-shares/news/ryman-healthcare-nzserym-valuation-check-as-earnings-outlook\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"RYM","symbol_name":"RYTHM Inc.","start_time":0,"source_url":"https://simplywall.st/stocks/nz/healthcare/nzx-rym/ryman-healthcare-shares/news/ryman-healthcare-nzserym-valuation-check-as-earnings-outlook","article_id":"2637369792","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6033000-choice2-main-header/1585186569462"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/nz/healthcare/nzx-rym/ryman-healthcare-shares/news/ryman-healthcare-nzserym-valuation-check-as-earnings-outlook","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2637369792","pubTimestamp":1779411137,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Ryman Healthcare (NZSE:RYM) has moved into focus after its stock declined ahead of the upcoming 26 May earnings report, with investors watching closely for commentary on profitability pressures and village occupancy trends.\nSee our latest analysis for Ryman Healthcare.\nRyman Healthcare's share price has been under pressure, with the 90 day share price return down 17.34% and the year to date share price return down 30.74%, while the 5 year total shareholder return has fallen 80.81%. This...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"RYM":"RYTHM Inc.","XLV":"健康照护类股ETF-SPDR","RYM.NZ":"Ryman Healthcare Limited Ordinary Shares"},"translate_title":"随着盈利前景和盈利计划成为焦点，Ryman Healthcare(NZSE：RYM)估值检查","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RYM.NZ":1.5,"XLV":1.5,"RYM":1.5},"content_text":"Ryman Healthcare (NZSE:RYM) has moved into focus after its stock declined ahead of the upcoming 26 May earnings report, with investors watching closely for commentary on profitability pressures and village occupancy trends. See our latest analysis for Ryman Healthcare. Ryman Healthcare's share price has been under pressure, with the 90 day share price return down 17.34% and the year to date share price return down 30.74%, while the 5 year total shareholder return has fallen 80.81%. This points to fading momentum as investors weigh ongoing profitability risks ahead of the earnings update. If this kind of sector uncertainty has you looking wider, it could be a good time to scan opportunities across 99 top founder-led companies With Ryman reporting a loss of NZ$564.027m and the stock down sharply over multiple time frames, the key question now is simple: are you looking at a beaten down opportunity or a stock already pricing in any future recovery? AdvertisementMost Popular Narrative: 35.1% Undervalued Against a last close of NZ$2.05, the most followed valuation narrative points to a fair value of NZ$3.16, setting up a clear gap for investors to weigh.  The company has embarked on a significant business reorganization to reduce costs and improve operational efficiency, including a focus on centralizing overheads and systems. This effort, resulting in $18 million in annualized savings, is expected to improve net margins over time.  Read the complete narrative. Want to see what could sit behind that cost reset story and the 7.3% discount rate? The narrative leans on a sharp swing in profitability and a richer revenue base. The full set of assumptions ties those moving parts directly to the NZ$3.16 fair value. Result: Fair Value of NZ$3.16 (UNDERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, there are still clear pressure points, including high debt of NZ$2.56b and weak cash flow from existing operations, that could unsettle confidence in the turnaround story. Find out about the key risks to this Ryman Healthcare narrative. Another View: Multiples Flash A Different Signal While the popular narrative points to NZ$3.16 as fair value, the current P/S of 2.6x looks expensive versus the Oceanic healthcare industry at 1x, peers at 2x, and a fair ratio of 1x. If sentiment cools, the share price could drift back toward that fair ratio. See what the numbers say about this price — find out in our valuation breakdown. NZSE:RYM P/S Ratio as at May 2026Next Steps Mixed signals on value and risk so far. If you want to move quickly and decide for yourself, review the 2 key rewards and 2 important warning signs to weigh the potential tradeoffs. Looking for more investment ideas? If Ryman is raising more questions than answers for you right now, broaden your watchlist and let the data surface other stocks that fit your style.  Target value plays that combine quality and potential mispricing with the help of 228 high quality undervalued stocks. Prioritize resilience by filtering for companies with stronger finances through the solid balance sheet and fundamentals stocks screener (392 results). Spot less crowded opportunities that still stack up fundamentally by scanning the screener containing 536 high quality undiscovered gems.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n        and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n        financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n        Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n        Simply Wall St has no position in any stocks mentioned.New: AI Stock Screener & AlertsOur new AI Stock Screener scans the market every day to uncover opportunities.• Dividend Powerhouses (3%+ Yield)• Undervalued Small Caps with Insider Buying• High growth Tech and AI CompaniesOr build your own from over 50 metrics.Explore Now for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2637369792","isCrawlerRequest":true}